DETROIT, MICH. – Susan G. Komen Greater Detroit® takes the health and safety of our supporters very seriously. As such, we are closely monitoring the news of the novel Coronavirus 2019 (COVID-19) and following guidance from public health officials and government agencies. On March 11, Governor Gretchen Whitmer addressed Michigan residents and urged people to “avoid gatherings of 100 people or more to prevent the possible spread of coronavirus.”

Actions We Are Taking:

  • We are investigating options to enable supporters to participate in the 29th Annual Komen Detroit Race for the Cure virtually or programing via live-stream. In addition, we are reviewing options to move the race to a later date in 2020.
  • Komen Greater Detroit offices will remain open and operate under normal business hours. However, this is subject to change as conditions and expert recommendations shift. Office closures will be communicated through our website and our social media pages. Should our offices close, our team will continue our operations remotely.
  • All meetings scheduled to be held with sponsors, volunteers and other supporters will be converted to virtual meetings through April 1, unless essential to be held in person. If you have a meeting scheduled with the Komen team, you will receive an email with virtual call-in information soon.

“We will be working to ensure that those who depend on our services can continue to reach out to us for assistance,” said Jaye Sciullo, executive director for Susan G. Komen Greater Detroit.

Breast Cancer doesn’t take a break, and we promise, neither do we. We will communicate updated KGD plans as they become available through e-blast, our website, and social media. Stay Connected: Facebook @Komen Greater Detroit and Instagram @Komen Greater Detroit.

Information about this outbreak is changing rapidly. The latest news is available at and

About Susan G. Komen Greater Detroit Affiliate®

The Susan G. Komen Greater Detroit Affiliate® was established as a 501c3 nonprofit organization in 2016, after separating from a successful partnership with the Barbara Ann Karmanos Cancer Institute that began in 1992. The inaugural Board of Directors were charged with building the framework of a $1 million–plus revenue generating affiliate within the national Susan G. Komen Affiliate network. The goal of the affiliate is to expand Komen’s work throughout southeast Michigan. To date, the Komen Greater Detroit affiliate has raised over $1.5 million, and helped to fund services provided at local community organizations including McLaren Cancer Institute (Clarkston), ACCESS (Arab Community Center for Economic and Social Services), BCCCP (Breast Cervical Cancer Control Program), Sisters Network in Detroit, and many others.

About Komen Detroit Race for the Cure®

The Komen Detroit Race for the Cure (RFTC) was established in 1992 in partnership with the Michigan Cancer Foundation, now known as the Barbara Ann Karmanos Cancer Institute. Since the first Detroit race in 1992, more than $29 million has been raised and invested in the fight against breast cancer. Twenty-five percent of the Detroit race net proceeds are dedicated to Komen’s national research grant program, and the remaining 75% is granted to local community organizations providing screening, treatment support and education in underserved communities. Since 1992, approximately $15,187,500 has been invested into local community grants.

About Susan G. Komen®

In 1980, Nancy G. Brinker promised her dying sister, Susan, that she would do everything in her power to end breast cancer forever. In 1982, that promise became the Susan G. Komen® organization, and the beginning of a global movement. What was started with $200 and a shoebox full of potential donor names has now grown into the world’s largest nonprofit source of funding for the fight against breast cancer. To date, they’ve invested more than $2.6 billion in groundbreaking research, community health outreach, advocacy and programs in more than 60 countries. Their efforts helped reduce death rates from breast cancer by 37%, between 1990- 2013, and they won’t stop until their promise is fulfilled.